Despite advances in the understanding of the in vitro molecular mechanisms of human T cell lymphotropic virus type 1 (HTLV-1), the development of appropriate and coordinated animal model systems to study the virus has not kept pace with this knowledge. The recent availability of molecular clones of the virus provides a unique opportunity to understand the pathogenesis of this important human pathogen. HTLV-1 infection exists worldwide, but is a particular problem in endemic regions of the United States. HTLV-1 infection causes adult T-cell leukemia/lymphoma (ATL) and is associated with a variety of immune- mediated disorders including HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV-1 is a complex retrovirus containing typical gag, pol, and env genes, as well as unique regulatory and accessory genes. Regulatory and accessory genes of HTLV-1 are encoded in four open reading frames (ORF I-IV) of the pX region of the virus. Tax, a 40 kD protein encoded from ORF IV plays a critical role in the regulation of both viral and cellular genes involved in lymphocyte proliferation. Rex, a 27 kD phosphoprotein, derived from ORF III, regulates the expression of incompletely spliced viral transcripts. It is not clear, however, what role ORFs I and II play in the pathogenesis of the virus infection. Our long term goal is to refine or develop animal models to study genetic determinants of HTLV-1 that allow the establishment of infection in vivo and lead to the transformation of CD4+ T lymphocytes. Our research group has established infectious molecular clones of HTLV-capable of CD4+ lymphocyte transformation as intact clones or with selective ablations of regulatory genes. In addition, we have developed Tax-independent HTLV-1 clones to differentiate the role of Tax from other regulatory elements of the virus. Using similar methods we were the first to identify a functional role of p12/I in establishment of infection in a rabbit model. Our collaborators, have adapted the SCID mouse model to address issues regarding HTLV-1 leukemogenesis and using transgenic mice have targeted Tax to the nature T lymphoid compartment providing new insight in the development of lymphoid tumors. We are now poised to develop and refine innovative animal model systems to address fundamental issues regarding the molecular mechanisms of the pathogenesis of HTLV-1 infection.
Specific aims that will be addressed in our infectivity of HTLV-1 and 2) Develop and evaluate SCID/beige and transgenic mouse model systems to test the in vitro and in vivo effects of selective mutations in tax and ORF I and II of htlv-1. Thus, we will compare the effects of each mutation in virus replication (rabbit model), tumor outgrowth in context to the full-length virus (SCID/bg model), and as isolated genes (transgenic model.) This type of comprehensive evaluation using common molecular clones has not been reported. Collectively, our research groups provide a coordinated approach to develop state-of-the-art animal models to further knowledge of the events of HTLV-1 pathogenesis.

National Institute of Health (NIH)
National Center for Research Resources (NCRR)
Research Project (R01)
Project #
Application #
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Program Officer
O'Neill, Raymond R
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Ohio State University
Veterinary Sciences
Schools of Veterinary Medicine
United States
Zip Code
Banerjee, Prabal; Tripp, Adam; Lairmore, Michael D et al. (2010) Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID mice. Blood 115:2640-8
Haynes 2nd, Rashade A H; Phipps, Andrew J; Yamamoto, Brenda et al. (2009) Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection. Viral Immunol 22:397-405
Shu, Sherry T; Nadella, Murali V P; Dirksen, Wessel P et al. (2007) A novel bioluminescent mouse model and effective therapy for adult T-cell leukemia/lymphoma. Cancer Res 67:11859-66
Kim, Seung-Jae; Nair, Amrithraj M; Fernandez, Soledad et al. (2006) Enhancement of LFA-1-mediated T cell adhesion by human T lymphotropic virus type 1 p12I1. J Immunol 176:5463-70
Nair, Amrithraj M; Michael, Bindhu; Datta, Antara et al. (2006) Calcium-dependent enhancement of transcription of p300 by human T-lymphotropic type 1 p12I. Virology 353:247-57
Lairmore, Michael D; Silverman, Lee; Ratner, Lee (2005) Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation. Oncogene 24:6005-15
Nair, Amrithraj; Michael, Bindhu; Hiraragi, Hajime et al. (2005) Human T lymphotropic virus type 1 accessory protein p12I modulates calcium-mediated cellular gene expression and enhances p300 expression in T lymphocytes. AIDS Res Hum Retroviruses 21:273-84
Hiraragi, Hajime; Michael, Bindhu; Nair, Amrithraj et al. (2005) Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13II sensitizes Jurkat T cells to Ras-mediated apoptosis. J Virol 79:9449-57
Altanerova, Veronika; Holicova, Dana; Kucerova, Lucia et al. (2004) Long-term infection with retroviral structural gene vector provides protection against bovine leukemia virus disease in rabbits. Virology 329:434-9
Silverman, Lee R; Phipps, Andrew J; Montgomery, Andrew et al. (2004) Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion. J Virol 78:3837-45

Showing the most recent 10 out of 34 publications